- Home
- ARI vs TVTX Comparison
ARI vs TVTX Comparison
Compare ARI & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARI
- TVTX
- Stock Information
- Founded
- ARI 2009
- TVTX 2008
- Country
- ARI United States
- TVTX United States
- Employees
- ARI N/A
- TVTX N/A
- Industry
- ARI Real Estate Investment Trusts
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ARI Real Estate
- TVTX Health Care
- Exchange
- ARI Nasdaq
- TVTX Nasdaq
- Market Cap
- ARI 1.1B
- TVTX 1.4B
- IPO Year
- ARI 2009
- TVTX N/A
- Fundamental
- Price
- ARI $9.84
- TVTX $14.79
- Analyst Decision
- ARI Hold
- TVTX Strong Buy
- Analyst Count
- ARI 5
- TVTX 16
- Target Price
- ARI $9.83
- TVTX $33.33
- AVG Volume (30 Days)
- ARI 1.5M
- TVTX 1.5M
- Earning Date
- ARI 08-05-2025
- TVTX 07-31-2025
- Dividend Yield
- ARI 10.19%
- TVTX N/A
- EPS Growth
- ARI N/A
- TVTX N/A
- EPS
- ARI N/A
- TVTX N/A
- Revenue
- ARI $276,844,000.00
- TVTX $273,533,000.00
- Revenue This Year
- ARI $32.11
- TVTX $73.84
- Revenue Next Year
- ARI $19.41
- TVTX $46.72
- P/E Ratio
- ARI N/A
- TVTX N/A
- Revenue Growth
- ARI 104.64
- TVTX 75.65
- 52 Week Low
- ARI $7.70
- TVTX $7.72
- 52 Week High
- ARI $11.20
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- ARI 50.04
- TVTX 44.21
- Support Level
- ARI $9.53
- TVTX $14.36
- Resistance Level
- ARI $9.91
- TVTX $15.27
- Average True Range (ATR)
- ARI 0.15
- TVTX 0.65
- MACD
- ARI -0.03
- TVTX 0.15
- Stochastic Oscillator
- ARI 46.30
- TVTX 63.64
About ARI Apollo Commercial Real Estate Finance Inc
Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.